Marie Brodbeck

Marie Brodbeck

InvestorPlace Contributor

Marie is a graduate of Duquesne University and has been a finance journalist for over a decade, when she began writing macroeconomic articles on a freelance basis. Since then, she has traveled the world and has been able to fund her lifestyle through a combination of savvy investments and frugal finances. She believes in taking risks when the market is fearful but always investing with a long-term view in mind.

Recent Articles

3 Reasons that Apple Stock Still Is a Buy, Even at Current Prices

By Marie Brodbeck, InvestorPlace Contributor

Don't let iPhone worries deter you, AAPL stock is still a great buy because of its loyal customers, growing services arm and impressive ecosystem.

LYV Stock Shows Promise, But it’s a No-Go at These Levels

By Marie Brodbeck, InvestorPlace Contributor

LYV is simply too expensive to be a buy right now. Live Nation Entertainment's future prospects look promising, but not as promising as its share price suggests. Investors who didn't buy LYV before its most recent rally might want to wait for a pullback.

3 Reasons ACN Stock Is a Solid Long-Term Investment

By Marie Brodbeck, InvestorPlace Contributor

Investors looking for a long-term stock they can buy and hold on to should consider ACN stock because the company's operations and strategic plans look promising.

Now’s the Time to Grab up Intel Stock Despite Analyst Handwringing

By Marie Brodbeck, InvestorPlace Contributor

Long-term investors might want to consider INTC stock while it's below $50 per share because the company's growth story looks unaffected by recent news headlines.

Remoxy’s Rejection Drives PTIE Stock 70% Lower

By Marie Brodbeck, InvestorPlace Contributor

The FDA Advisory Committee's decision to vote against Remoxy has left PTIE stock in the dumps because the firm has very few other options coming up the pipeline.

Load More